P55 MULTIPLE MYELOMA AND SARS-COV-2 INFECTION: AN EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA) OF 1,221 PATIENTS THROUGH THE DIFFERENT PHASES OF COVID-19 PANDEMIC
Main Authors: | P. Musto, J. Salmanton-García, N. Sgherza, R. Bergantim, F. Farina, A. Glenthøj, G.C. Seval, B. Weinbergerová, V. Bonuomo, Y.M. Bilgin, L. Rahimli, F. Marchesi, O.A. Cornely, L. Pagano |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-05-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000936348.78046.5c |
Similar Items
-
MOLNUPIRAVIR (MOL) COMPARADO A NIRMATRELVIR/RITONAVIR (NIRI) PARA COVID-19 EM PACIENTES DE ALTO RISCO COM MALIGNIDADE HEMATOLÓGICA NA EUROPA: UMA ANÁLISE PAREADA DO REGISTRO EPICOVIDEHA
by: Jon Salmanton-García, et al.
Published: (2023-10-01) -
NIRMATRELVIR/RITONAVIR (NIRI) EM PACIENTES COM COVID-19 E MALIGNIDADES HEMATOLÓGICAS: RELATO DO EPICOVIDEHA (REGISTRO INTERNACIONAL ONLINE DE PACIENTES COM MALIGNIDADES HEMATOLÓGICAS, INFECTADOS POR SARS-COV-2)
by: Jon Salmanton-García, et al.
Published: (2023-10-01) -
Unveiling the Hidden Burden: From EPICOVIDEHA to EPIFLUEHA, Exploring the Epidemiology of Respiratory Viral Infections in Hematological Patients
by: Jon Salmanton-García, et al.
Published: (2023-11-01) -
P1514: MOLNUPIRAVIR COMPARED TO NIRMATRELVIR/RITONAVIR FOR COVID-19 IN HIGH-RISK PATIENTS WITH HAEMATOLOGICAL MALIGNANCY IN EUROPE. A MATCHED-PAIRED ANALYSIS FROM THE EPICOVIDEHA REGISTRY
by: Jon Salmanton-García, et al.
Published: (2023-08-01) -
EPICOVIDEHA: A Ready to Use Platform for Epidemiological Studies in Hematological Patients With COVID-19
by: Jon Salmanton-García, et al.
Published: (2021-07-01)